Condition: Depressive Disorder, Major · Sponsor: Eli Lilly and Company
This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying the return of major depressive symptoms. The trial is divided into three periods as follows: a screening period that will last approximately 1 month, a treatment period that will last a minimum of 12 months, and the follow up period that will last approximately 2 months. The duration of study participation may vary and may be shortened if depression symptoms worsen or if withdrawal from the study occurs for any reason.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Accellacare - Moorpark | Moorpark, California, United States | Recruiting |
| ATP Clinical Research | Orange, California, United States | Recruiting |
| Yale University School of Medicine | New Haven, Connecticut, United States | Recruiting |
| Encore Medical Research | Hollywood, Florida, United States | Recruiting |
| K2 Medical Research - Maitland | Maitland, Florida, United States | Recruiting |
| Life Medical Research Group Corp | Miami Gardens, Florida, United States | Recruiting |
| Floridian Clinical Research, LLC | Miami Lakes, Florida, United States | Recruiting |
| CLA Research | Naples, Florida, United States | Recruiting |
| Optimal Research Sites | Orange City, Florida, United States | Recruiting |
| Charter Research - Orlando | Orlando, Florida, United States | Recruiting |
| K2 Medical Research - Tampa | Tampa, Florida, United States | Recruiting |
| CenExel iResearch, LLC | Decatur, Georgia, United States | Recruiting |
+ 168 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07412756